Trials / Unknown
UnknownNCT03645187
Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer
Evaluation of Anticancer Effect of Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study aimed at evaluation of anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer
Detailed description
The primary aim of the study is to evaluate the anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FOLFERI | FOLFERI regimen |
| DRUG | Folferi and celecoxib | Folferi regimen and celecoxib |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2025-08-01
- Completion
- 2025-12-01
- First posted
- 2018-08-24
- Last updated
- 2021-04-20
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03645187. Inclusion in this directory is not an endorsement.